You are here

Article info

Article menu
Download PDFPDF
PostScript
Letter
Dopamine agonist withdrawal syndrome (DAWS) in a patient with a microprolactinoma

Authors

  1. Correspondence to Dr Mark Edwards, Sobell Department, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK; m.j.edwards{at}ucl.ac.uk
View Full Text

Citation

Demartini B, Ricciardi L, Ward A, et al
Dopamine agonist withdrawal syndrome (DAWS) in a patient with a microprolactinoma
Journal of Neurology, Neurosurgery & Psychiatry 2014;85:471.

Publication history

  • Received July 26, 2013
  • Revised September 11, 2013
  • Accepted September 12, 2013
  • First published September 27, 2013.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions